*By Michael Teich*
[Twelve percent](https://migraineresearchfoundation.org/about-migraine/migraine-facts/) of the U.S. population may suffer from chronic migraines, but many Americans don't appreciate the impact, said president of Lilly Bio-Medicines Christi Shaw.
"These patients need to be treated seriously. This is a neurological disorder," Shaw said Friday in an interview on Cheddar.
Eli Lilly ($LLY) just received clearance from the FDA for its latest drug, and it could change the lives of the 39 million Americans suffering from migraines, according to Shaw.
The treatment, Emgality, is a monthly, self-administered injection that will help patients cut the frequency of their migraines in half, she said.
Shaw said that many Americans conflate headaches and migraines, and so they often dismiss their pain. They key difference is that the symptoms of a migraine disrupt one's ability to function optimally through the day. That doesn't happen with a more commonplace headache. And a stigma contributes to the glaring statistic that only about 10 percent of those suffering from migraines take prescription drugs for prevention, Shaw said.
Emgality comes with a serious price tag: $6,900 a year, or $575 a month. But Eli Lilly is offering commercially insured patients up to 12 months of the drug for free. It's among the latest efforts from the industry to offer consumers some relief from surging drug costs.
Competitors Amgen ($AMGN) and Teva ($TEVA) have already unveiled new migraine treatment drugs.
For full interview [click here](https://cheddar.com/videos/eli-lilly-gets-fda-approval-for-new-migraine-treatment).
OceanGate Expeditions on Thursday said pilot and chief executive Stockton Rush, along with passengers Shahzada Dawood and his son Suleman Dawood, Hamish Harding, and Paul-Henri Nargeolet “have sadly been lost.”
A new study on loneliness is showing it may not only affect mental health, but it may also be bad for the bones. However, the study found it impacts one group in particular: men. Amid concerns about the rising epidemic of loneliness, researchers wanted to take a closer look at its effects.
Be Well: 2-Minute Morning Stretch Routine
Be Well: Celebrity Trainer Bob Harper Talks Heart Health
A new study from Finland found that "night owls," or people who tend to stay up late, don't live as long as those who go to bed early and wake up early as well.
Confidence in the scientific community declined among U.S. adults in 2022, a major survey shows, driven by a partisan divide in views of both science and medicine that emerged during the COVID-19 pandemic.
The American Cancer Society estimates that over 20,000 new cancer cases in Connecticut this year alone. But there's a concerning shortage of chemotherapy drugs in the state and across the country. News 12 reporter Mark Sudol tells us why and what can be done.
A jury in Oregon says the electric utility PacifiCorp must pay punitive damages for causing devastating wildfires in 2020 — on top of an earlier verdict already expected to amount to billions of dollars.
Pfizer is warning that an antibiotic used to treat syphilis and other bacterial infections in young people are likely to run out by the end of this quarter.
Be Well: Alex Rodriguez on the Importance of Dental Hygiene Following Gum Disease Diagnosis
